Related Experiment Videos
Causal link between folic acid and recurrent aphthous ulcers: A two-sample Mendelian randomization study.
TieXin Gao1,2, TianYang Chen3, YuLong Xu2
1Department of Oncology, Hospital of Traditional Chinese Medicine of Jiujiang, Jiujiang, China.
Medicine
|June 16, 2026
Summary
This study used Mendelian randomization to investigate links between micronutrients and recurrent aphthous ulcers (RAU). Genetically predicted folic acid levels showed a potential association with increased RAU risk.
Area of Science:
- Genetics
- Nutritional Science
- Oral Medicine
Background:
- Observational studies suggest links between micronutrient status and recurrent aphthous ulcers (RAU).
- The causal relationship between micronutrients and RAU remains unclear.
- Mendelian randomization (MR) offers a method to explore potential causal associations using genetic variants.
Purpose of the Study:
- To genetically evaluate the association between circulating micronutrients and RAU risk.
- To employ a two-sample MR approach using genome-wide association study (GWAS) data.
- To investigate 15 different micronutrients for their potential impact on RAU.
Main Methods:
- Two-sample Mendelian randomization analysis utilizing GWAS summary statistics.
- Genetic instruments for 15 micronutrients sourced from the IEU OpenGWAS database.
- RAU outcome data from the FinnGen consortium (5394 cases).
- Primary analysis using the Inverse Variance Weighted (IVW) method, with Weighted Median and MR-Egger for sensitivity.
- Sensitivity analyses to assess heterogeneity and horizontal pleiotropy.
Main Results:
- A nominally significant association was found between genetically predicted folic acid levels and increased RAU risk (OR=2.05, P=0.009) via the IVW method.
- Other MR methods indicated a consistent direction of effect but with wide confidence intervals.
- No statistically significant associations were identified for the other 14 micronutrients.
- Sensitivity analyses did not reveal substantial heterogeneity or horizontal pleiotropy.
Conclusions:
- This MR study provides preliminary genetic evidence suggesting a potential link between genetically predicted folic acid levels and RAU risk.
- The findings, particularly the nominal significance from the IVW analysis, warrant cautious interpretation due to potential limitations.
- Further research is needed to confirm these results and understand the underlying biological mechanisms, without implying direct dietary recommendations.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...